Micronized Progesterone (Prometrium) is a bioidentical hormone pivotal in hormone replacement therapy, safeguarding the endometrium during estrogen use. Recent FDA updates highlight its vital role for women with an intact uterus, showcasing its superior safety and tolerability compared to synthetic progestins.
Mechanism
Micronized progesterone binds to specific receptors in target tissues, notably transforming the proliferative endometrium into a secretory phase. This transition drastically minimizes the risk of endometrial hyperplasia and cancer when paired with estrogen. Moreover, its neuroactive metabolites interact with GABA-A receptors in the brain, providing calming effects and enhancing sleep quality.
Research
Clinical trials reveal a striking contrast in endometrial hyperplasia rates: just 6% with combined therapy versus 64% with estrogen alone over three years. Micronized progesterone also boasts a safer profile regarding breast tissue stimulation compared to synthetic alternatives, indicating a lower risk of breast cancer.
Synergies
When paired with estrogen therapy, micronized progesterone amplifies endometrial protection and positively influences mood. Ben IQ customizes strategies based on YOUR unique labs and health goals to optimize your hormone balance.
Trade-Offs
Though micronized progesterone is often the preferred choice, higher doses can lead to sedation or cognitive effects, and its lipid profile varies from estrogen. Personalized guidance informed by YOUR data is essential for tailored care.